Lakefront Biotherapeutics (LKFT) Exchange Rate Effect (2014 - 2026)
Lakefront Biotherapeutics (LKFT) reported Exchange Rate Effect of $819522.0 for Q1 2026, up 159.98% year-over-year from $315228.9 in Q1 2025, and up 152.27% quarter-over-quarter from -$1.6 million in Q4 2025.
Lakefront Biotherapeutics (LKFT) Exchange Rate Effect (2014 - 2026) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has 13 years of Exchange Rate Effect data on file, last reported at $819522.0 in Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at $819522.0, up 159.98% year-over-year; the trailing twelve-month figure through Mar 2026 was -$694679.3 (down 11216.31% YoY), and the FY2025 annual result was $3.5 million, up 83.2% from the prior year.
- Exchange Rate Effect improved to $819522.0 in Q1 2026 per LKFT's latest filing, from -$1.6 million in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $18.4 million in Q1 2022 and troughed at -$3.8 million in Q4 2022.
- A 5-year average of $1.3 million and a median of $100600.9 in 2023 frame the typical range for Exchange Rate Effect.
- On a YoY basis, Exchange Rate Effect climbed as much as 769.8% in 2025 and fell as far as 352.06% in 2025.
- A 5-year view of Exchange Rate Effect shows it stood at -$3.8 million in 2022, then jumped by 74.15% to -$984485.0 in 2023, then jumped by 244.25% to $1.4 million in 2024, then slumped by 210.41% to -$1.6 million in 2025, then jumped by 152.27% to $819522.0 in 2026.
- Business Quant data shows LKFT's Exchange Rate Effect at $819522.0 in Q1 2026, -$1.6 million in Q4 2025, and $3.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 8.68 Mn |
| 10 | Lakefront Biotherapeutics | 9.64 Bn | 9.64 Bn | 1.97 Mn | 819,521.96 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 819,521.96 |
| Mar 31, 2026 | 819,521.96 |
| Dec 31, 2025 | -1.57 Mn |
| Dec 31, 2025 | -1.57 Mn |
| Sep 30, 2025 | 3.57 Mn |
| Sep 30, 2025 | 3.57 Mn |
| Jun 30, 2025 | 3.28 Mn |
| Jun 30, 2025 | 3.28 Mn |
| Mar 31, 2025 | -1.37 Mn |
| Mar 31, 2025 | -1.37 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Sep 30, 2024 | -533,734.68 |
| Sep 30, 2024 | -533,734.68 |
| Jun 30, 2024 | 473,830.53 |
| Jun 30, 2024 | 473,830.53 |
| Mar 31, 2024 | 542,094.52 |
| Mar 31, 2024 | 542,094.52 |
| Dec 31, 2023 | -984,485.02 |
| Dec 31, 2023 | -984,485.02 |